181 related articles for article (PubMed ID: 18976753)
1. Sexual function in first-time contraceptive ring and contraceptive patch users.
Gracia CR; Sammel MD; Charlesworth S; Lin H; Barnhart KT; Creinin MD
Fertil Steril; 2010 Jan; 93(1):21-8. PubMed ID: 18976753
[TBL] [Abstract][Full Text] [Related]
2. Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners.
Guida M; Di Spiezio Sardo A; Bramante S; Sparice S; Acunzo G; Tommaselli GA; Di Carlo C; Pellicano M; Greco E; Nappi C
Hum Reprod; 2005 Apr; 20(4):1100-6. PubMed ID: 15608030
[TBL] [Abstract][Full Text] [Related]
3. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis.
Vercellini P; Barbara G; Somigliana E; Bianchi S; Abbiati A; Fedele L
Fertil Steril; 2010 May; 93(7):2150-61. PubMed ID: 19328469
[TBL] [Abstract][Full Text] [Related]
4. [Combined hormonal contraception in cycles artificially extended].
Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
[TBL] [Abstract][Full Text] [Related]
6. Comparing patient telephone callback rates for different hormonal birth control delivery systems.
Victor I; Fink RA
Am J Ther; 2006; 13(6):507-12. PubMed ID: 17122531
[TBL] [Abstract][Full Text] [Related]
7. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.
Roumen FJ; Dieben TO
Fertil Steril; 2006 Jan; 85(1):57-62. PubMed ID: 16412731
[TBL] [Abstract][Full Text] [Related]
8. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
Westhoff C; Osborne LM; Schafer JE; Morroni C
Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
[TBL] [Abstract][Full Text] [Related]
9. Prospective study on sexual behavior of women using 30 microg ethinylestradiol and 3 mg drospirenone oral contraceptive.
Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Sparacino L; Cianci A
Contraception; 2005 Jul; 72(1):19-23. PubMed ID: 15964287
[TBL] [Abstract][Full Text] [Related]
10. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
[TBL] [Abstract][Full Text] [Related]
11. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
Creasy GW; Fisher AC; Hall N; Shangold GA
J Reprod Med; 2003 Mar; 48(3):179-86. PubMed ID: 12698776
[TBL] [Abstract][Full Text] [Related]
12. Progress in contraception: new technology.
Linn ES
Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551
[TBL] [Abstract][Full Text] [Related]
13. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
Contraception; 2009 Jul; 80(1):34-9. PubMed ID: 19501213
[TBL] [Abstract][Full Text] [Related]
14. Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
O'Connell KJ; Osborne LM; Westhoff C
Contraception; 2005 Nov; 72(5):323-7. PubMed ID: 16246655
[TBL] [Abstract][Full Text] [Related]
15. Extended regimens of the vaginal contraceptive ring: cycle control.
Guazzelli CA; Barreiros FA; Barbosa R; de Araújo FF; Moron AF
Contraception; 2009 Nov; 80(5):430-5. PubMed ID: 19835716
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial.
Oddsson K; Leifels-Fischer B; de Melo NR; Wiel-Masson D; Benedetto C; Verhoeven CH; Dieben TO
Contraception; 2005 Mar; 71(3):176-82. PubMed ID: 15722066
[TBL] [Abstract][Full Text] [Related]
17. Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study.
Leone Roberti Maggiore U; Remorgida V; Scala C; Tafi E; Venturini PL; Ferrero S
Acta Obstet Gynecol Scand; 2014 Mar; 93(3):239-47. PubMed ID: 24372517
[TBL] [Abstract][Full Text] [Related]
18. Self-described impact of noncompliance among users of a combined hormonal contraceptive method.
Lete I; Doval JL; Pérez-Campos E; Lertxundi R; Correa M; de la Viuda E; Gómez MA; González JV; Martínez MT; Mendoza N; Robledo J
Contraception; 2008 Apr; 77(4):276-82. PubMed ID: 18342651
[TBL] [Abstract][Full Text] [Related]
19. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
Bruni V; Pontello V; Luisi S; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):65-71. PubMed ID: 18358586
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
Kluft C; Meijer P; LaGuardia KD; Fisher AC
Contraception; 2008 Feb; 77(2):77-83. PubMed ID: 18226669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
